21 CFR 520.1880

§ 520.1880 Prednisolone.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.1880, § 520.1880 Prednisolone, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87288
Permanent ID: ys:prov:87288@1
SHA-256: b912a256abbb83ee8bb4153307d2bda6614125fb3add3033dcc6b6bf74457bac

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each tablet contains 5 or 20 milligrams prednisolone. (b) Sponsor. See No. 061690 in § 510.600(c)(2) of this chapter. (c) Conditions of use in dogs—(1) Amount. Administer 2.5 milligrams per 4.5 kilograms (10 pounds) body weight per day. Administer total daily dose orally in equally divided doses 6 to 10 hours apart until response is noted or 7 days have elapsed. When response is attained, dosage should be gradually reduced until maintenance level is achieved. (2) Indications for use. For use as an anti-inflammatory agent. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.